Additional file 5: of MiRNA-17 encoded by the miR-17-92 cluster increases the potential for steatosis in hepatoma cells by targeting CYP7A1

Figure S3. Luciferase activity changed in mouse psiCHECK-CYP7A1 and miR-17 co-transfection but not for psiCHECK-CYP7A1 mutant. (JPG 120 kb

Additional file 2: of MiRNA-17 encoded by the miR-17-92 cluster increases the potential for steatosis in hepatoma cells by targeting CYP7A1

Figure S4. miR-17 expression level was stable in miR-17 transgenic mice. (JPG 829 kb

Additional file 1: of MiRNA-17 encoded by the miR-17-92 cluster increases the potential for steatosis in hepatoma cells by targeting CYP7A1

Figure S1. Expression of miR-17 increases in transgenic mice compared with wild-type mice. (JPG 599 kb

Additional file 5: of MiRNA-17 encoded by the miR-17-92 cluster increases the potential for steatosis in hepatoma cells by targeting CYP7A1

Figure S3. Luciferase activity changed in mouse psiCHECK-CYP7A1 and miR-17 co-transfection but not for psiCHECK-CYP7A1 mutant. (JPG 120 kb

Additional file 3: of MiRNA-17 encoded by the miR-17-92 cluster increases the potential for steatosis in hepatoma cells by targeting CYP7A1

Figure S2. A – CYP7A1 is predicted to be a target of miR-17 in humans. B – CYP7A1 is predicted to be a target of miR-17 in mice. (JPG 87 kb